Mrs Donna Kay Haynes, BA; BHRS | |
111 S Main St, Mcalester, OK 74501-5363 | |
(918) 470-4280 | |
(580) 371-2056 |
Full Name | Mrs Donna Kay Haynes |
---|---|
Gender | Female |
Speciality | Psychologist - Rehabilitation |
Location | 111 S Main St, Mcalester, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821315532 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TR0400X | Psychologist - Rehabilitation | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Donna Kay Haynes, BA; BHRS 111 S Main St, Mcalester, OK 74501-5363 Ph: (918) 470-4280 | Mrs Donna Kay Haynes, BA; BHRS 111 S Main St, Mcalester, OK 74501-5363 Ph: (918) 470-4280 |
News Archive
Reporting at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week, new research shows that sleep deprivation leads to changes in the levels of key proteins that facilitate events involved in the underlying pathology of migraine.
A team of heart experts at Johns Hopkins has found that dual lab tests of blood clotting factors accurately predict the patients whose blood vessels, in particular veins implanted to restore blood flow to the heart during coronary artery bypass grafting, are more likely to fail or become clogged within six months.
The results of a study presented today at the European League Against Rheumatism Annual Congress showed that when antibodies develop in response to the biological treatment Remicade (infliximab), they also cross-react with the biosimilar of infliximab (CT-P13: Inflectra or Remsima).
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, today announced the initiation of a phase 2 study of its investigational protein therapeutic, ACE-536, to treat anemia in patients with myelodysplastic syndromes (MDS).
Shire plc has announced that DAYTRANA (methylphenidate transdermal system), its Attention Deficit Hyperactivity Disorder (ADHD) patch, had significant efficacy in reducing the symptoms of ADHD in both male and female children aged 6 to 12 years, according to clinical trial results reported at the American Psychiatric Association (APA) annual meeting in San Diego.
› Verified 5 days ago
Dr. Kathleen Ward, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 609 S 2nd St, Mcalester, OK 74501 Phone: 918-302-0203 | |
Jana S Barnes, M,ED, BHRS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 721 S George Nigh Expy, Mcalester, OK 74501 Phone: 918-302-0909 | |
Marissa Kaylee Crenshaw, SCHOOL PSYCHOLOGIST Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2004 N Hickory St, Mcalester, OK 74501 Phone: 918-721-6986 | |
Stephen Kyle Cox, BS BHRS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 111 S Main St, Mcalester, OK 74501 Phone: 918-423-5205 Fax: 918-423-5255 | |
Sharilyn Rogers Tomlin, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 111 S Main St, Mcalester, OK 74501 Phone: 918-426-5206 Fax: 918-423-5255 | |
David W Gwin, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 111 S Main, Mcalester, OK 74501 Phone: 918-423-5204 Fax: 918-423-5255 | |
Nicole Laub, BS, BHRS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 111 S Main St, Mcalester, OK 74501 Phone: 918-308-0127 |